As demand for lentiviral (LV) vectors for both ex vivo cell-based and in vivo gene therapy applications grows, the question of how to make LV vector processing faster, more productive, and more cost-effective becomes increasingly pressing.
In this webinar, LV processing and quality experts from across the biotech, CDMO and tool provider sectors will discuss how recent technological innovation in specific upstream and downstream LV process steps compare in terms of their impact on titer, process speed, and of course, cost.
Attend this webinar to find out: